JP2016532695A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016532695A5 JP2016532695A5 JP2016532339A JP2016532339A JP2016532695A5 JP 2016532695 A5 JP2016532695 A5 JP 2016532695A5 JP 2016532339 A JP2016532339 A JP 2016532339A JP 2016532339 A JP2016532339 A JP 2016532339A JP 2016532695 A5 JP2016532695 A5 JP 2016532695A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- vitamin
- group
- formula
- structure according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims 16
- 150000001875 compounds Chemical class 0.000 claims 16
- 229930003316 Vitamin D Natural products 0.000 claims 15
- 235000019166 vitamin D Nutrition 0.000 claims 15
- 239000011710 vitamin D Substances 0.000 claims 15
- 229940046008 vitamin d Drugs 0.000 claims 15
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 10
- 238000000034 method Methods 0.000 claims 10
- 150000003710 vitamin D derivatives Chemical group 0.000 claims 10
- 239000000700 radioactive tracer Substances 0.000 claims 7
- -1 vitamin D compound Chemical class 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 239000003153 chemical reaction reagent Substances 0.000 claims 3
- JWUBBDSIWDLEOM-UHFFFAOYSA-N 25-Hydroxycholecalciferol Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CCC1=C JWUBBDSIWDLEOM-UHFFFAOYSA-N 0.000 claims 2
- JWUBBDSIWDLEOM-DCHLRESJSA-N 25-Hydroxyvitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C/C=C1\C[C@@H](O)CCC1=C JWUBBDSIWDLEOM-DCHLRESJSA-N 0.000 claims 2
- JWUBBDSIWDLEOM-NQZHSCJISA-N 25-hydroxy-3 epi cholecalciferol Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@H](O)CCC1=C JWUBBDSIWDLEOM-NQZHSCJISA-N 0.000 claims 2
- KJKIIUAXZGLUND-ICCVIKJNSA-N 25-hydroxyvitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](\C=C\[C@H](C)C(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C KJKIIUAXZGLUND-ICCVIKJNSA-N 0.000 claims 2
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 2
- 239000013060 biological fluid Substances 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 238000002372 labelling Methods 0.000 claims 2
- 238000005259 measurement Methods 0.000 claims 2
- 239000000758 substrate Substances 0.000 claims 2
- GMRQFYUYWCNGIN-UHFFFAOYSA-N 1,25-Dihydroxy-vitamin D3' Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CC(O)C1=C GMRQFYUYWCNGIN-UHFFFAOYSA-N 0.000 claims 1
- ZGLHBRQAEXKACO-XJRQOBMKSA-N 1alpha,25-dihydroxyvitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](\C=C\[C@H](C)C(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C ZGLHBRQAEXKACO-XJRQOBMKSA-N 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 125000004057 biotinyl group Chemical group [H]N1C(=O)N([H])[C@]2([H])[C@@]([H])(SC([H])([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 229960005084 calcitriol Drugs 0.000 claims 1
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000002860 competitive effect Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000002270 dispersing agent Substances 0.000 claims 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N ergocalciferol group Chemical group CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@H]2\C(\CCC[C@]12C)=C\C=C/1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims 1
- 230000000144 pharmacologic effect Effects 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 1
- 235000005282 vitamin D3 Nutrition 0.000 claims 1
- 239000011647 vitamin D3 Substances 0.000 claims 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims 1
- 229940021056 vitamin d3 Drugs 0.000 claims 1
- 0 *C(*)(CCOC(*)(*)CCNC(CCC*[C@@](C1N2)SC[C@]1(N)NC2O)=O)C(N)=O Chemical compound *C(*)(CCOC(*)(*)CCNC(CCC*[C@@](C1N2)SC[C@]1(N)NC2O)=O)C(N)=O 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102013215580.8 | 2013-08-07 | ||
| DE102013215580.8A DE102013215580A1 (de) | 2013-08-07 | 2013-08-07 | 25-OH Vitamin D Derivate zur Bestimmung von Vitamin D Metaboliten |
| PCT/EP2014/066620 WO2015018757A1 (de) | 2013-08-07 | 2014-08-01 | 25-oh vitamin d derivate zur bestimmung von vitamin d metaboliten |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016532695A JP2016532695A (ja) | 2016-10-20 |
| JP2016532695A5 true JP2016532695A5 (enExample) | 2017-06-15 |
| JP6388941B2 JP6388941B2 (ja) | 2018-09-12 |
Family
ID=51298740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016532339A Active JP6388941B2 (ja) | 2013-08-07 | 2014-08-01 | ビタミンｄ代謝物を測定するための２５−ｏｈビタミンｄ誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10222388B2 (enExample) |
| EP (1) | EP3030243B1 (enExample) |
| JP (1) | JP6388941B2 (enExample) |
| CN (1) | CN105636595B (enExample) |
| AU (1) | AU2014304585A1 (enExample) |
| DE (1) | DE102013215580A1 (enExample) |
| IL (1) | IL243856A0 (enExample) |
| MX (1) | MX2016001519A (enExample) |
| RU (1) | RU2016108014A (enExample) |
| WO (1) | WO2015018757A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016065042A1 (en) | 2014-10-22 | 2016-04-28 | Extend Biosciences, Inc. | Therapeutic vitamin d conjugates |
| WO2016065052A1 (en) | 2014-10-22 | 2016-04-28 | Extend Biosciences, Inc. | Insulin vitamin d conjugates |
| US20160161473A1 (en) | 2014-12-08 | 2016-06-09 | Calbiotech, Inc. | Biotin conjugates of analytes containing amino, hydroxyl, or thiol functional groups for use in immunodiagnostic assays |
| CN111518008B (zh) * | 2019-02-01 | 2023-02-28 | 科美博阳诊断技术(上海)有限公司 | 用于测定维生素d的含量或存在的化合物、产品和方法 |
| CN115850141B (zh) * | 2019-02-01 | 2024-09-20 | 科美博阳诊断技术(上海)有限公司 | 一种中间体化合物及其制备方法和应用 |
| CN112485418B (zh) * | 2020-10-26 | 2023-04-11 | 北京利德曼生化股份有限公司 | 一种用于人体维生素b12含量检测的释放剂及其应用 |
| JP2025534350A (ja) | 2022-09-30 | 2025-10-15 | エクステンド バイオサイエンシズ インコーポレーテッド | 長時間作用型副甲状腺ホルモン |
| CN119192387B (zh) * | 2023-06-25 | 2025-11-18 | 东莞市朋志生物科技有限公司 | 抗25-oh-vd及其抗体复合物的抗体、检测25-oh-vd的试剂和试剂盒 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4119647A (en) * | 1977-04-11 | 1978-10-10 | Hoffmann-La Roche Inc. | 25-Hydroxycholecalciferol-23,24-3 H and process for the preparation thereof |
| JPH075542B2 (ja) | 1988-09-14 | 1995-01-25 | 呉羽化学工業株式会社 | ビタミンｄ▲下３▼誘導体及びその製造方法 |
| CH681891A5 (enExample) | 1992-10-09 | 1993-06-15 | Marigen Sa | |
| US5422127A (en) * | 1992-12-21 | 1995-06-06 | Bristol-Myers Squibb Company | Nutritional compositions containing vitamin D esters |
| US5478816A (en) * | 1993-07-02 | 1995-12-26 | Bristol-Myers Squibb Company | Liquid vitamin formulations containing vitamin D esters |
| WO1997024127A1 (en) * | 1995-12-29 | 1997-07-10 | A And D Assay, Incorporated | Labeled vitamin d compounds and the use thereof |
| GB9623569D0 (en) | 1996-11-13 | 1997-01-08 | Immunodiagnostic Systems Ltd | Vitamin D immumoassay systems |
| US6017908A (en) | 1997-05-16 | 2000-01-25 | Women And Infants Hospital | 3-EPI vitamin D2 compounds and uses thereof |
| DE19981132D2 (de) | 1998-06-25 | 2001-10-18 | Immundiagnostik Ges Fuer Produ | Funktionelle Vitamin-D-Derivate und Verfahren zur Bestimmung von 25-Hydroxy- und 1alpha,25-Dihydroxy-Vitamin-D |
| CA2624124A1 (en) | 2005-09-29 | 2007-04-12 | F. Hoffmann-La Roche Ag | Antibodies against 25-hydroxyvitamin d |
| JP5572318B2 (ja) * | 2005-12-30 | 2014-08-13 | ルバンス セラピュティックス インク． | 局所投与用アルギニンヘテロマー |
| KR20090025239A (ko) | 2006-05-16 | 2009-03-10 | 프리스케일 세미컨덕터, 인크. | 패드 및 입출력(ｉ／ｏ) 셀을 갖는 집적 회로 |
| ES2336382T3 (es) | 2006-06-06 | 2010-04-12 | F. Hoffmann-La Roche Ag | Medicion mejorada de la vitamina d. |
| JP2010053118A (ja) | 2008-07-28 | 2010-03-11 | Fujifilm Corp | ビオチン化チロキシン |
| CN102628872A (zh) * | 2012-03-31 | 2012-08-08 | 广州菲康生物技术有限公司 | 25羟基维生素d检测试剂盒及其制备方法 |
| DE102013205055A1 (de) | 2013-03-21 | 2014-09-25 | Orgentec Diagnostika Gmbh | Verfahren und Reagenz zur Bestimmung von Vitamin D Metaboliten |
-
2013
- 2013-08-07 DE DE102013215580.8A patent/DE102013215580A1/de not_active Withdrawn
-
2014
- 2014-08-01 JP JP2016532339A patent/JP6388941B2/ja active Active
- 2014-08-01 EP EP14748179.0A patent/EP3030243B1/de active Active
- 2014-08-01 US US14/910,881 patent/US10222388B2/en active Active
- 2014-08-01 CN CN201480044453.2A patent/CN105636595B/zh active Active
- 2014-08-01 MX MX2016001519A patent/MX2016001519A/es unknown
- 2014-08-01 WO PCT/EP2014/066620 patent/WO2015018757A1/de not_active Ceased
- 2014-08-01 RU RU2016108014A patent/RU2016108014A/ru unknown
- 2014-08-01 AU AU2014304585A patent/AU2014304585A1/en not_active Abandoned
-
2016
- 2016-01-31 IL IL243856A patent/IL243856A0/en unknown
-
2018
- 2018-10-04 US US16/151,812 patent/US11199553B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016532695A5 (enExample) | ||
| RU2016108014A (ru) | Производные 25-он витамина d для определения метаболитов витамина d | |
| Wu et al. | Bioconjugated persistent luminescence nanoparticles for Föster resonance energy transfer immunoassay of prostate specific antigen in serum and cell extracts without in situ excitation | |
| KR102412431B1 (ko) | 신장 질환을 검출하기 위한 방법 | |
| RU2013127156A (ru) | Реагент для высвобождения витамина d | |
| ATE530915T1 (de) | Freisetzungsreagens für vitamin-d-verbindungen | |
| DK2718293T3 (da) | Substituerede pyridopyraziner som hidtil ukendte syk-inhibitorer | |
| ZA202002415B (en) | Detection of symmetrical dimethylarginine | |
| JP2013510934A (ja) | 両性イオン含有アクリジニウム化合物 | |
| JP2015536446A5 (enExample) | ||
| CA2865254A1 (en) | Compositions and methods for in vitro diagnostic tests including sulfonic acid | |
| WO2009013884A1 (ja) | 鉛濃度測定用試薬及び鉛濃度測定方法 | |
| CN104569404A (zh) | 直接竞争trfia法检测喹乙醇的方法 | |
| US20210395606A1 (en) | Chromophoric structures for macrocyclic lanthanide chelates | |
| DE602006019575D1 (de) | Zusammensetzungen und verfahren zur erkennung von sirolimus | |
| JP2008275592A5 (enExample) | ||
| EA201370030A1 (ru) | Бифункциональный количественный анализ in vitro связывания мишени для обнаружения нейтрализующих антител к антителам-мишеням | |
| FI3259593T3 (fi) | Homogeeninen immunomääritys, jossa on taustasignaalikompensointi | |
| WO2006124456A3 (en) | Competitive particle immunoassay methods utilizing fluorescence microscopy | |
| WO2016100113A3 (en) | Conjugates for assays for oxycodone and oxymorphone | |
| WO2008126780A1 (ja) | 食品中タンパク質の高感度検出法 | |
| JP2016524140A (ja) | 分解可能なカチオン界面活性剤および化学発光を増強するためのその利用 | |
| PL408905A1 (pl) | Nowy związek, sposób jego otrzymywania, roztwór farmaceutyczny zawierający nowy związek, sposób określania obecności choroby nowotworowej, zestaw do wykrywania nowotworów oraz zastosowanie hydrolizy nowego związku do wykrywania nowotworów | |
| BR112016030560A8 (pt) | parceiros de ligação específicos para epímeros de vitamina d, anticorpo e método para separar uma vitamina d epimérica de uma amostra suspeita de conter uma vitamina d epimérica | |
| KR20110137370A (ko) | 면역 분석 방법 및 그것을 위한 시약 |